Abbott Labs’ dissolving stent ‘next revolution?’ (Morning Read)
Abbott Laboratories' dissolving stent "may truly become the next revolution," John Capek, Abbott's executive vice president of medical devices told Bloomberg.
Indiana’s Symmetry Medical announces layoffs, factory closing as a result of weakened orthopedics market
In moves that Symmetry says will save $3.4 million annually, the company will close its Auburn, Maine, manufacturing plant and cut an unspecified number of its 2,500 worldwide employees.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
Shares of Indiana’s Symmetry Medical slide after orthopedic implant maker slashes profit, revenue outlook for 2009
Shares of Symmetry Medical Inc. fell 18 percent Monday after the maker of orthopedic implants and related instruments slashed its 2009 profit and revenue outlooks. Symmetry Medical shares fell $1.72 to $7.84 Monday on the New York Stock Exchange.